Exact Mass: 314.2821

Exact Mass Matches: 314.2821

Found 259 metabolites which its exact mass value is equals to given mass value 314.2821, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

12,13-DiHOME

(9Z,12S,13S)-12,13-dihydroxyoctadec-9-enoic acid

C18H34O4 (314.2457)


12,13-DHOME (CAS: 263399-35-5), also known as 12,13-dihydroxy-9-octadecenoic acid or 12,13-DiHOME, is the epoxide hydrolase metabolite of the leukotoxin 12,13-EpOME. 12,13-EpOME acts as a protoxin, with the corresponding epoxide hydrolase 12,13-DHOME specifically exerting toxicity. Both the EpOME and the DHOME are shown to have neutrophil chemotactic activity. 12,13-DHOME suppress the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4, which inhibit multiple aspects of neutrophil activation. 12,13-DHOME is a derivative of the linoleic acid diol that has been reported to be toxic in human tissue preparations. 12,13-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation (PMID: 17435320, 12021203, 12127265). 12,13-DHOME is the epoxide hydrolase metabolite of the leukotoxin12,13-EpOME. 12,13-EpOMEs act as a protoxin, with the corresponding epoxide hydrolase 12,13-DiHOME specifically exerting toxicity. Both the EpOME and the DiHOME are shown to have neutrophil chemotactic activity. 12,13-DiHOME suppress the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4,which inhibit multiple aspects of neutrophil activation. 12,13-DHOME is a derivative of linoleic acid diol that have been reported to be toxic in humans tissue preparations. 12,13-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation. (PMID: 17435320, 12021203, 12127265) [HMDB]

   

9,10-DiHOME

(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C18H34O4 (314.2457)


9,10-Dihydroxy-12-octadecenoic acid (CAS: 263399-34-4), also known as 9,10-DHOME, is a derivative of linoleic acid diol and has been reported to be toxic in humans tissue preparations. 9,10-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation. 9,10-DHOME is the epoxide hydrolase metabolite of the leukotoxin 9,10-EpOME. 9,10-EpOME act as a protoxin, with the corresponding epoxide hydrolase metabolite 9,10-DHOME, specifically exerting toxicity. Both 9,10-EpOME and 9,10-DHOME are shown to have neutrophil chemotactic activity. 9,10-DHOME suppresses the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4, which inhibit multiple aspects of neutrophil activation (PMID: 12021203, 12127265, 17435320). 9,10-DHOME is found in fruits and can be isolated from the seeds of Cucurbita pepo. 9,10-DHOME is a derivative of linoleic acid diol that have been reported to be toxic in humans tissue preparations. 9,10-DHOME is a naturally occurring proliferator-activated receptor (PPAR) gamma2 ligand, which stimulates adipocytes and inhibits osteoblast differentiation. 9,10-DHOME is the epoxide hydrolase metabolite of the leukotoxin 9,10--EpOME. 9,10-EpOMEs act as a protoxin, with the corresponding epoxide hydrolase 9,10-DiHOME specifically exerting toxicity. Both the 9,10-EpOME and the 9,10-DiHOME are shown to have neutrophil chemotactic activity. 9,10-DiHOME suppress the neutrophil respiratory burst by a mechanism distinct from that of respiratory burst inhibitors such as cyclosporin H or lipoxin A4,which inhibit multiple aspects of neutrophil activation. (PMID: 12021203, 12127265, 17435320) [HMDB]

   

7S,8S-DiHOME

(9Z)-(7S,8S)-Dihydroxyoctadecenoic acid; (Z)-(7S,8S)-Dihydroxyoctadeca-9-enoic acid; (Z)-(7S,8S)-Dihydroxyoctadeca-9-enoate

C18H34O4 (314.2457)


   

9,10-Epoxy-18-hydroxy-octadecanoic acid

8-[3-(8-hydroxyoctyl)oxiran-2-yl]octanoic acid

C18H34O4 (314.2457)


9,10-epoxy-18-hydroxy-octadecanoic acid, also known as 9,10-epoxy-18-hydroxystearate, is a member of the class of compounds known as medium-chain fatty acids. Medium-chain fatty acids are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 9,10-epoxy-18-hydroxy-octadecanoic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 9,10-epoxy-18-hydroxy-octadecanoic acid can be found in a number of food items such as wheat, deerberry, common beet, and rocket salad, which makes 9,10-epoxy-18-hydroxy-octadecanoic acid a potential biomarker for the consumption of these food products.

   

10S-hydroperoxy-8E-octadecenoic acid

(8E,10S)-10-Hydroperoxyoctadeca-8-enoate; (8E,10S)-10-Hydroperoxy-8-octadecenoate

C18H34O4 (314.2457)


   

Dibutyl decanedioate

Decanedioic acid, 1,10-dibutyl ester

C18H34O4 (314.2457)


Dibutyl decanedioate, also known as DBS or butyl sebacate, belongs to the class of organic compounds known as fatty acid esters. These are carboxylic ester derivatives of a fatty acid. Dibutyl decanedioate is a potentially toxic compound. Flavouring ingredient used in fruit food flavouring

   

ctadecanedioate (C18-DC)

1,16-Hexadecanedicarboxylic acid

C18H34O4 (314.2457)


Octadecanedioic acid, also known as 1,18-octadecanedioate or octadecane-1,18-dioate, belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. In the case of octadecanedioic acid, it has carboxyl groups at both ends of the chain, not just one. Octadecanedioic acid is a very hydrophobic molecule, practically insoluble (in water). Octadecanedioic acid is a long-chain dicarboxylic acid normally not found in humans that has been identified in the blood serum in Reyes syndrome patients (PMID: 3746531). There may also be an association with colorectal cancer (PMID: 25037050). Octadecanedioic acid is a long-chain dicarboxylic acid normally not found in humans that has been identified in blood serum in Reyes syndrome patients (PMID 3746531) [HMDB] Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1]. Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1].

   

9,10-Epoxyoctadecanoic acid

8-[(2R,3S)-3-(8-hydroxyoctyl)oxiran-2-yl]octanoic acid

C18H34O4 (314.2457)


9,10-Epoxyoctadecanoic acid (CAS: 3233-92-9), also known as 9,10-epoxystearate, belongs to the class of organic compounds known as linoleic acids and derivatives. These are derivatives of linoleic acid. Linoleic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions. 9,10-Epoxyoctadecanoic acid is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 9,10-Epoxyoctadecanoic acid is an epoxy fatty acid. Epoxy fatty acids bear an oxirane ring that shares a CC-bond with the aliphatic chain. The cis-9,10-epoxyoctadecanoic acid has been found in liver microsomes and is believed to originate from CYP-catalyzed epoxidation of oleic acid.

   

1,20-Eicosanediol

icosane-1,20-diol

C20H42O2 (314.3185)


1,20-Eicosanediol is found in pomes. 1,20-Eicosanediol occurs in Carnauba wax and apple wax. Occurs in Carnauba wax and apple wax. 1,20-Eicosanediol is found in pomes.

   

13-HDoHE

(3Z,6E,8E,12Z,15Z,18Z)-docosa-3,6,8,12,15,18-hexaen-10-ol

C22H34O (314.261)


13-HDoHE is an autoxidation product of docosahexaenoic acid DHA. 13-HDoHE is a long-chain polyunsaturated fatty acid that is any docosahexaenoic acid bearing a single hydroxy substituent. An oxidation product of docosahexaenoic acid metabolism. (CHEBI:72790)

   

3-hydroxypristanic acid

3-hydroxy-2,6,10,14-tetramethylpentadecanoic acid

C19H38O3 (314.2821)


3-Hydroxypristanic acid fatty acid that is formed via hydroxylation of pristanic acid at the 3-poisition. This reaction has been found to occur in the human liver.

   

cis-4-Decenoylcarnitine

(3R)-3-[(4Z)-Dec-4-enoyloxy]-4-(trimethylazaniumyl)butanoic acid

C17H32NO4 (314.2331)


cis-4-Decenoylcarnitine is an acylcarnitine. More specifically, it is an cis-4-decenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. cis-4-Decenoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine cis-4-decenoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. In particular cis-4-decenoylcarnitine is elevated in the blood or plasma of individuals with overweight (PMID: 30322392). It is also decreased in the blood or plasma of individuals with schizophrenia (PMID: 31161852) and familial mediterranean fever (PMID: 29900937). cis-4-Decenoylcarnitine has also been identified in the human placenta (PMID: 32033212 ). Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-(Octadecyloxy)ethanol

Octadecyl polyoxyethylene ether, potassium phosphate salt

C20H42O2 (314.3185)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

Diamsar chelate

1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane

C14H34N8 (314.2906)


   

ACMC-20m5sy

ACMC-20m5sy

C22H34O (314.261)


   

2-methoxyoctadecanoic acid

2-methoxyoctadecanoic acid

C19H38O3 (314.2821)


   

Carbonic acid, pentadecyl propyl ester

Carbonic acid, pentadecyl propyl ester

C19H38O3 (314.2821)


   

SCHEMBL19634237

SCHEMBL19634237

C20H30N2O (314.2358)


   

12,13-DIHYDROXYOCTADEC-2-ENOIC ACID

12,13-DIHYDROXYOCTADEC-2-ENOIC ACID

C18H34O4 (314.2457)


   

9,10-dihydroxyoctadecenoic acid

9,10-dihydroxyoctadecenoic acid

C18H34O4 (314.2457)


   

Conarrhimin|Conarrhimin (3beta-Amino-N-desmethyl-con-5-enin)|conarrhimine|Connarrhimin

Conarrhimin|Conarrhimin (3beta-Amino-N-desmethyl-con-5-enin)|conarrhimine|Connarrhimin

C21H34N2 (314.2722)


   

Methyl 2-acetyloxypentadecanoate

Methyl 2-acetyloxypentadecanoate

C18H34O4 (314.2457)


   

Niphatesine E

Niphatesine E

C20H30N2O (314.2358)


   

5,12-dihydroxyoctadec-6(Z)-enoic acid

5,12-dihydroxyoctadec-6(Z)-enoic acid

C18H34O4 (314.2457)


   

niphatesine B

niphatesine B

C21H34N2 (314.2722)


   

15-Hydroxynonadecanoic acid

15-Hydroxynonadecanoic acid

C19H38O3 (314.2821)


   

Icosane-1,2-diol

Icosane-1,2-diol

C20H42O2 (314.3185)


   

18-Hydroxynonadecanoic acid

18-Hydroxynonadecanoic acid

C19H38O3 (314.2821)


   

plakortether B

plakortether B

C18H34O4 (314.2457)


   

1-O-hexadecenylglycerol

1-O-hexadecenylglycerol

C19H38O3 (314.2821)


   

penicitide A

penicitide A

C18H34O4 (314.2457)


   

methyl 18-hydroxyoctadecanoate

methyl 18-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

SCHEMBL3501701

SCHEMBL3501701

C18H34O4 (314.2457)


   
   

yucalexin B-22

yucalexin B-22

C22H34O (314.261)


   

2-hydroxy-17-methyloctadecanoic acid

2-hydroxy-17-methyloctadecanoic acid

C19H38O3 (314.2821)


   

1,16-eicosanediol

1,16-eicosanediol

C20H42O2 (314.3185)


   

2-Hydroxy-16-methyl-octadecan-1-saeure

2-Hydroxy-16-methyl-octadecan-1-saeure

C19H38O3 (314.2821)


   

3-Acetoxy-palmitic acid

3-Acetoxy-palmitic acid

C18H34O4 (314.2457)


   

3-Hexadecen-2-one, 16-phenyl-, (3E)-

3-Hexadecen-2-one, 16-phenyl-, (3E)-

C22H34O (314.261)


   

dihydroplakortin|endoperoxide 9,10-dihydroplakortin

dihydroplakortin|endoperoxide 9,10-dihydroplakortin

C18H34O4 (314.2457)


   

SCHEMBL2915915

SCHEMBL2915915

C20H42O2 (314.3185)


   

woodylide A

woodylide A

C18H34O4 (314.2457)


   

Methyl 2-hydroxyoctadecanoate

Methyl 2-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

fruticosoline

fruticosoline

C20H30N2O (314.2358)


   

Methyl 3-hydroxyoctadecanoate

Methyl 3-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

Methyl 17-hydroxyoctadecanoate

Methyl 17-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

wrightiamine A

wrightiamine A

C21H34N2 (314.2722)


A steroid alkaloid isolated from Wrightia javanica and has been shown to exhibit antineoplastic activity.

   

(Z)-15-Docosene-1,3-diyn-5-one|docos-15-cis-ene-1,3-diyn-5-one|docos-15c-ene-1,3-diyn-5-one

(Z)-15-Docosene-1,3-diyn-5-one|docos-15-cis-ene-1,3-diyn-5-one|docos-15c-ene-1,3-diyn-5-one

C22H34O (314.261)


   

7,10-DIHYDROXYOCTADEC-8-ENOIC ACID

7,10-DIHYDROXYOCTADEC-8-ENOIC ACID

C18H34O4 (314.2457)


   

12-Hydroxynonadecanoic acid

12-Hydroxynonadecanoic acid

C19H38O3 (314.2821)


   

SCHEMBL15257455

SCHEMBL15257455

C22H34O (314.261)


   

Pedicellinsaeure

Pedicellinsaeure

C18H34O4 (314.2457)


   

16-acetoxyhexadecanoic acid

16-acetoxyhexadecanoic acid

C18H34O4 (314.2457)


   

Methyl 10-hydroxystearate

Methyl 10-hydroxystearate

C19H38O3 (314.2821)


   

5-[5-(1-HYDROXYNONYL)OXOLAN-2-YL]PENTANOIC ACID

5-[5-(1-HYDROXYNONYL)OXOLAN-2-YL]PENTANOIC ACID

C18H34O4 (314.2457)


   

Methyl 9-hydroxystearate

Methyl 9-hydroxystearate

C19H38O3 (314.2821)


   

18-methylnonadecane-1,2-diol

18-methylnonadecane-1,2-diol

C20H42O2 (314.3185)


   

Dimethyl hexadecanedioate

Dimethyl hexadecanedioate

C18H34O4 (314.2457)


   

(5S,8R,9Z)-5,8-Dihydroxy-9-octadecenoic acid

(5S,8R,9Z)-5,8-Dihydroxy-9-octadecenoic acid

C18H34O4 (314.2457)


   

9,10-DiHOME

9,10-DiHOME

C18H34O4 (314.2457)


A DiHOME obtained by formal dihydroxylation of the 9,10-double bond of octadeca-9,12-dienoic acid (the 12Z-geoisomer).

   

8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid

NCGC00381425-01!8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid

C18H34O4 (314.2457)


   

Octadecanedioic acid

Octadecanedioic acid

C18H34O4 (314.2457)


An alpha,omega-dicarboxylic acid that is octadecane in which both terminal methyl groups have been replaced by carboxy groups. Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1]. Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1].

   

FA 18:1+2O

FA 18:1+2O

C18H34O4 (314.2457)


Annotation level-3 Annotation level-2

   
   

(9xi,10xi,12xi)-9,10-Dihydroxy-12-octadecenoic acid

(9xi,10xi,12xi)-9,10-Dihydroxy-12-octadecenoic acid

C18H34O4 (314.2457)


   

8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid [IIN-based on: CCMSLIB00000846585]

NCGC00381425-01!8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid [IIN-based on: CCMSLIB00000846585]

C18H34O4 (314.2457)


   

8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid [IIN-based: Match]

NCGC00381425-01!8-hydroxy-8-(3-octyloxiran-2-yl)octanoic acid [IIN-based: Match]

C18H34O4 (314.2457)


   

DIBUTYL SEBACATE

DIBUTYL SEBACATE

C18H34O4 (314.2457)


   

9,10-dihydroxy-12-octadecenoic acid

9,10-dihydroxy-12-octadecenoic acid

C18H34O4 (314.2457)


   

9,13-dihydroxy-10-octadecenoic acid

9,13-dihydroxy-10-octadecenoic acid

C18H34O4 (314.2457)


   

9,13-dihydroxy-11-octadecenoic acid

9,13-dihydroxy-11-octadecenoic acid

C18H34O4 (314.2457)


   

12,13-dihydroxy-9-octadecenoic acid

12,13-dihydroxy-9-octadecenoic acid

C18H34O4 (314.2457)


   

18-hydroxy-9R,10S-epoxy-stearic acid

18-hydroxy-9R,10S-epoxy-octadecanoic acid

C18H34O4 (314.2457)


   

18-hydroxy-9S,10R-epoxy-stearic acid

18-hydroxy-9S,10R-epoxy-octadecanoic acid

C18H34O4 (314.2457)


   

(±)12,13-DiHOME

12,13-dihydroxy-9Z-octadecenoic acid

C18H34O4 (314.2457)


   

13-methyl-1,2-nonadecanediol

13-methyl-1,2-nonadecanediol

C20H42O2 (314.3185)


   

1,2-eicosanediol

eicosane-1,2-diol

C20H42O2 (314.3185)


   

11-HpOME

11-hydroperoxy-12Z-octadecenoic acid

C18H34O4 (314.2457)


   

9-HpOME

9-hydroperoxy-10E-octadecenoic acid

C18H34O4 (314.2457)


   

8-HpOME

8-hydroperoxy-9Z-octadecenoic acid

C18H34O4 (314.2457)


   

10-HpOME

10-hydroperoxy-8E-octadecenoic acid

C18H34O4 (314.2457)


   

2-hydroxy-nonadecanoic acid

2-hydroxy-nonadecanoic acid

C19H38O3 (314.2821)


   

19-hydroxy-nonadecanoic acid

19-hydroxy-nonadecanoic acid

C19H38O3 (314.2821)


   

9,10-DiHOME(12)

9,10-dihydroxy-12-octadecenoic acid

C18H34O4 (314.2457)


   

9,13-DiHOME(10)

9,13-dihydroxy-10-octadecenoic acid

C18H34O4 (314.2457)


   

9,13-DiHOME(11)

9,13-dihydroxy-11-octadecenoic acid

C18H34O4 (314.2457)


   

12,13-DiHOME(9)

12,13-dihydroxy-9-octadecenoic acid

C18H34O4 (314.2457)


   

1,20-Icosanediol

icosane-1,20-diol

C20H42O2 (314.3185)


   

Reomol DBS

Decanedioic acid, 1,10-dibutyl ester

C18H34O4 (314.2457)


   

10S-HpOME

10S-hydroperoxy-8E-octadecenoic acid

C18H34O4 (314.2457)


   

7S,10S-diHOME

7S,10S-dihydroxy-8E-octadecenoic acid

C18H34O4 (314.2457)


   

8R-HpOME

8R-hydroperoxy-9Z-octadecenoic acid

C18H34O4 (314.2457)


   

5S,8R-DiHOME

5S,8R-dihydroxy-9Z-octadecenoic acid

C18H34O4 (314.2457)


   

8R,11S-DiHOME

8R,11S-dihydroxy-9Z-octadecenoic acid

C18H34O4 (314.2457)


   

11R-HpOME

11R-hydroperoxy-12Z-octadecenoic acid

C18H34O4 (314.2457)


   

13R-HpOME

13R-hydroperoxy-11E-octadecenoic acid

C18H34O4 (314.2457)


   

13S-HpOME

13S-hydroperoxy-11E-octadecenoic acid

C18H34O4 (314.2457)


   

12R-HpOME

12R-hydroperoxy-13Z-octadecenoic acid

C18H34O4 (314.2457)


   

12S-HpOME

12S-hydroperoxy-13Z-octadecenoic acid

C18H34O4 (314.2457)


   

14R-HpOME

14R-hydroperoxy-12E-octadecenoic acid

C18H34O4 (314.2457)


   

14S-HpOME

14S-hydroperoxy-12E-octadecenoic acid

C18H34O4 (314.2457)


   

10R-HpOME

10R-hydroperoxy-11Z-octadecenoic acid

C18H34O4 (314.2457)


   

7-HpOME

7-hydroperoxy-5E-octadecenoic acid

C18H34O4 (314.2457)


   

12-HpOME

12-hydroperoxy10E-octadecenoic acid

C18H34O4 (314.2457)


   

6-HpOME

6-hydroperoxy-7E-octadecenoic acid

C18H34O4 (314.2457)


   

3Z,6Z,9Z,12Z,15Z-Tricosapentaene

3Z,6Z,9Z,12Z,15Z-Tricosapentaene

C23H38 (314.2973)


   

FA 19:0;O

3-Hydroxy-11-methyloctadecanoic acid

C19H38O3 (314.2821)


   

AC1NQXX5

(Z,7R,8S)-7,8-dihydroxyoctadec-9-enoic acid

C18H34O4 (314.2457)


   

FA 18:1;O2

9-Octadecenoic acid, 12,13-dihydroxy-, (9Z,12S,13S)-

C18H34O4 (314.2457)


Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1]. Octadecanedioic acid, an endogenous metabolite, is a long-chain dicarboxylic acid that has been found in serum free fatty acid profile in Reye syndrome[1].

   

Turneroic acid

11-hydroxy-12,13-epoxy-octadecanoic acid

C18H34O4 (314.2457)


   

FOH 20:0;O

13-methyl-1,2-nonadecanediol

C20H42O2 (314.3185)


   

14-(tert-Butoxy)-14-oxotetradecanoic acid

14-(tert-Butoxy)-14-oxotetradecanoic acid

C18H34O4 (314.2457)


   

Trihexyl borate

Trihexyl borate

C18H39BO3 (314.2992)


   

1-Eicosanethiol

1-Eicosanethiol

C20H42S (314.3007)


   

(2,2-2H2)Icosanoic acid

(2,2-2H2)Icosanoic acid

C20H38D2O2 (314.3154)


   

Dihexyl adipate

Dihexyl adipate

C18H34O4 (314.2457)


   

diethyl tetradecanedioate

diethyl tetradecanedioate

C18H34O4 (314.2457)


   

di-n-decyl sulfide

di-n-decyl sulfide

C20H42S (314.3007)


   

UNII:P7UC7KGL82

UNII:P7UC7KGL82

C19H38O3 (314.2821)


   

1-Dodecyl-3-Methyl-1H-Imidazolium Nitrate

1-Dodecyl-3-Methyl-1H-Imidazolium Nitrate

C16H32N3O3 (314.2444)


   

1,1,3,3-Tetramethylbutyl peroxyneodecanoate

1,1,3,3-Tetramethylbutyl peroxyneodecanoate

C18H34O4 (314.2457)


   

Ceraphyl 28

Ceraphyl 28

C19H38O3 (314.2821)


   

3,5,5-Trimethylhexanoyl peroxide

3,5,5-Trimethylhexanoyl peroxide

C18H34O4 (314.2457)


   

Isononanoyl peroxide

Isononanoyl peroxide

C18H34O4 (314.2457)


   

1,1-[isobutylidenebis(oxy)]bis[2-ethylhexane]

1,1-[isobutylidenebis(oxy)]bis[2-ethylhexane]

C20H42O2 (314.3185)


   

Octanoic acid,1,1-(1,2-ethanediyl) ester

Octanoic acid,1,1-(1,2-ethanediyl) ester

C18H34O4 (314.2457)


   

1-tetradecyl-3-methylimidazolium chloride

1-tetradecyl-3-methylimidazolium chloride

C18H35ClN2 (314.2489)


   

Poly(ethylene glycol) bis(2-ethylhexanoate)

Poly(ethylene glycol) bis(2-ethylhexanoate)

C18H34O4 (314.2457)


   

4-[(trans,trans)-4-Butyl[1,1-bicyclohexyl]-4-yl]phenol

4-[(trans,trans)-4-Butyl[1,1-bicyclohexyl]-4-yl]phenol

C22H34O (314.261)


   

8-Hydroxyoctadecanoic acid methyl ester

8-Hydroxyoctadecanoic acid methyl ester

C19H38O3 (314.2821)


   

2-Hydroxynonadecanoic acid

2-Hydroxynonadecanoic acid

C19H38O3 (314.2821)


A 2-hydroxy fatty acid that is nonadecanoic acid substituted by a hydroxy group at position 2.

   

8-[(2S,3R)-3-(8-Hydroxyoctyl)oxiran-2-yl]octanoic acid

8-[(2S,3R)-3-(8-Hydroxyoctyl)oxiran-2-yl]octanoic acid

C18H34O4 (314.2457)


   

19-Hydroxynonadecanoic acid

19-Hydroxynonadecanoic acid

C19H38O3 (314.2821)


An omega-hydroxy fatty acid that is nonadecanoic acid in which one of the hydrogens of the terminal methyl group has been replaced by a hydroxy group.

   

(Hexadecanoyloxy)acetic acid

(Hexadecanoyloxy)acetic acid

C18H34O4 (314.2457)


   

n-Pentanoic acid, trimethylsilyl ester

n-Pentanoic acid, trimethylsilyl ester

C18H38O2Si (314.2641)


   

C18E1

Poly(oxy-1,2-ethanediyl), .alpha.-octadecyl-.omega.-hydroxy-

C20H42O2 (314.3185)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

5,9,13,17-Tetramethyloctadeca-2,4,8,12,16-pentaenal

5,9,13,17-Tetramethyloctadeca-2,4,8,12,16-pentaenal

C22H34O (314.261)


   

[3-carboxy-2-[(E)-dec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-4-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[(2R)-3-carboxy-2-[(Z)-dec-4-enoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(Z)-dec-4-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

(3-Carboxy-2-dec-9-enoyloxypropyl)-trimethylazanium

(3-Carboxy-2-dec-9-enoyloxypropyl)-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(Z)-dec-4-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(Z)-dec-4-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-2-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-8-methylnon-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-8-methylnon-6-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-3-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-3-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-6-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-6-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-7-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-5-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-5-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[3-carboxy-2-[(E)-dec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-dec-8-enoyl]oxypropyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxododec-4-enyl]-trimethylazanium

[(E)-2-(carboxymethyl)-2-hydroxy-3-oxododec-4-enyl]-trimethylazanium

C17H32NO4+ (314.2331)


   

8-Hydroxy-9,10-epoxystearic acid

8-Hydroxy-9,10-epoxystearic acid

C18H34O4 (314.2457)


   

1-Trimethylsilyloctadeca-1,3,5-triyne

1-Trimethylsilyloctadeca-1,3,5-triyne

C21H34Si (314.243)


   

(-)-3-(4-Phenylbutyl)cyclododecanone

(-)-3-(4-Phenylbutyl)cyclododecanone

C22H34O (314.261)


   

[1-(3-Phenylpropyl)-4-piperidinyl]-(1-piperidinyl)methanone

[1-(3-Phenylpropyl)-4-piperidinyl]-(1-piperidinyl)methanone

C20H30N2O (314.2358)


   

17-Hydroxy-9,10-epoxystearic acid

17-Hydroxy-9,10-epoxystearic acid

C18H34O4 (314.2457)


   

[(2R,3S,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

[(2R,3S,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

C20H30N2O (314.2358)


   

(6Z,9Z,12Z,15Z)-1,6,9,12,15-tricosapentaene

(6Z,9Z,12Z,15Z)-1,6,9,12,15-tricosapentaene

C23H38 (314.2973)


   

[(2R,3S,4R)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

[(2R,3S,4R)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

C20H30N2O (314.2358)


   

[(2S,3S,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

[(2S,3S,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

C20H30N2O (314.2358)


   

[(2S,3R,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

[(2S,3R,4S)-4-[(cyclobutylmethylamino)methyl]-1-(cyclopropylmethyl)-3-phenyl-2-azetidinyl]methanol

C20H30N2O (314.2358)


   

1-O-[(E)-hexadecen-1-yl]-sn-glycerol

1-O-[(E)-hexadecen-1-yl]-sn-glycerol

C19H38O3 (314.2821)


   

(18R)-18-hydroxynonadecanoic acid

(18R)-18-hydroxynonadecanoic acid

C19H38O3 (314.2821)


An (omega-1)-hydroxy fatty acid that is nonadecanoic acid in which the 18-pro-R hydrogen is replaced by a hydroxy group.

   

(Z,12R)-12,18-dihydroxyoctadec-9-enoic acid

(Z,12R)-12,18-dihydroxyoctadec-9-enoic acid

C18H34O4 (314.2457)


   

(2R)-2-Hydroperoxyoleic acid

(2R)-2-Hydroperoxyoleic acid

C18H34O4 (314.2457)


   

(2R,3R)-2-ethyl-3-hydroxy-4-[2-[(4S,5S)-4-methoxy-5-methylheptan-2-yl]cyclopropyl]butanoic acid

(2R,3R)-2-ethyl-3-hydroxy-4-[2-[(4S,5S)-4-methoxy-5-methylheptan-2-yl]cyclopropyl]butanoic acid

C18H34O4 (314.2457)


   

(E,10R)-10-hydroperoxyoctadec-8-enoic acid

(E,10R)-10-hydroperoxyoctadec-8-enoic acid

C18H34O4 (314.2457)


   

Fahfa 9:0/9:0

Fahfa 9:0/9:0

C18H34O4 (314.2457)


   

Tetradecanoic acid, 12-methyl, trimethylsilyl ester

Tetradecanoic acid, 12-methyl, trimethylsilyl ester

C18H38O2Si (314.2641)


   

2,3-dihydroxypropyl (Z)-pentadec-9-enoate

2,3-dihydroxypropyl (Z)-pentadec-9-enoate

C18H34O4 (314.2457)


   

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] acetate

[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] acetate

C18H34O4 (314.2457)


   

[(2S)-2,3-dihydroxypropyl] (E)-pentadec-9-enoate

[(2S)-2,3-dihydroxypropyl] (E)-pentadec-9-enoate

C18H34O4 (314.2457)


   

Fahfa 2:0/16:0

Fahfa 2:0/16:0

C18H34O4 (314.2457)


   

Fahfa 4:0/14:0

Fahfa 4:0/14:0

C18H34O4 (314.2457)


   

Fahfa 14:0/4:0

Fahfa 14:0/4:0

C18H34O4 (314.2457)


   

Fahfa 12:0/6:0

Fahfa 12:0/6:0

C18H34O4 (314.2457)


   

Fahfa 10:0/8:0

Fahfa 10:0/8:0

C18H34O4 (314.2457)


   

Fahfa 6:0/12:0

Fahfa 6:0/12:0

C18H34O4 (314.2457)


   

Fahfa 7:0/11:0

Fahfa 7:0/11:0

C18H34O4 (314.2457)


   

Fahfa 8:0/10:0

Fahfa 8:0/10:0

C18H34O4 (314.2457)


   

Fahfa 3:0/15:0

Fahfa 3:0/15:0

C18H34O4 (314.2457)


   

Fahfa 13:0/5:0

Fahfa 13:0/5:0

C18H34O4 (314.2457)


   

Fahfa 15:0/3:0

Fahfa 15:0/3:0

C18H34O4 (314.2457)


   

Fahfa 5:0/13:0

Fahfa 5:0/13:0

C18H34O4 (314.2457)


   

Fahfa 11:0/7:0

Fahfa 11:0/7:0

C18H34O4 (314.2457)


   

9,10-epoxy-18-hydroxyoctadecanoic acid

9,10-epoxy-18-hydroxyoctadecanoic acid

C18H34O4 (314.2457)


An epoxy fatty acid that is 9,10-epoxyoctadecanoic acid (9,10-epoxystearic acid) carrying an additional hydroxy substituent at position 18.

   

(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoate

(Z)-(7S,8S)-Dihydroxyoctadeca-9-enoate

C18H34O4 (314.2457)


   

12,13-DHOA

(9Z)-12,13-Dihydroxyoctadec-9-enoic acid

C18H34O4 (314.2457)


A DiHOME obtained by formal dihydroxylation of the 12,13-double bond of octadeca-9,12-dienoic acid (the 9Z-geoisomer).

   

1,20-Eicosanediol

1,20-Eicosanediol

C20H42O2 (314.3185)


   

(9R,10S)-9,10-epoxy-18-hydroxyoctadecanoic acid

(9R,10S)-9,10-epoxy-18-hydroxyoctadecanoic acid

C18H34O4 (314.2457)


A 9,10-epoxy-18-hydroxyoctadecanoic acid in which the chiral centres at positions 9 and 10 have R- and S-configuration respectively.

   

9,10-DHOA

(12Z)-9,10-Dihydroxyoctadec-12-enoic acid

C18H34O4 (314.2457)


9,10-DiHOME is a DiHOME obtained by formal dihydroxylation of the 9,10-double bond of octadeca-9,12-dienoic acid (the 12Z-geoisomer). It is a conjugate acid of a 9,10-DiHOME(1-).

   

1,2-icosanediol

1,2-eicosanediol

C20H42O2 (314.3185)


   

12,13-dihydroxyoctadec-9-enoic acid

12,13-dihydroxyoctadec-9-enoic acid

C18H34O4 (314.2457)


   

(9S,10R)-9,10-epoxy-18-hydroxyoctadecanoic acid

(9S,10R)-9,10-epoxy-18-hydroxyoctadecanoic acid

C18H34O4 (314.2457)


A 9,10-epoxy-18-hydroxyoctadecanoic acid in which the chiral centres at positions 9 and 10 have S- and R-configuration respectively.

   

icosane-1,3-diol

icosane-1,3-diol

C20H42O2 (314.3185)


   

10-methoxyoctadecanoic acid

10-methoxyoctadecanoic acid

C19H38O3 (314.2821)


   

10-hydroperoxy-8E-octadecenoic acid

10-hydroperoxy-8E-octadecenoic acid

C18H34O4 (314.2457)


A hydroperoxy fatty acid that is 10-hydroperoxy derivative of (8E)-octadecenoic acid.

   

9-hydroperoxy-10E-octadecenoic acid

9-hydroperoxy-10E-octadecenoic acid

C18H34O4 (314.2457)


A hydroperoxy fatty acid that is 9-hydroperoxy derivative of (10E)-octadecenoic acid.

   

11-methoxyoctadecanoic acid

11-methoxyoctadecanoic acid

C19H38O3 (314.2821)


   

13R-hydroperoxy-11E-octadecenoic acid

13R-hydroperoxy-11E-octadecenoic acid

C18H34O4 (314.2457)


   

(8R)-hydroperoxyoleic acid

(8R)-hydroperoxyoleic acid

C18H34O4 (314.2457)


   

11R-hydroperoxy-12Z-octadecenoic acid

11R-hydroperoxy-12Z-octadecenoic acid

C18H34O4 (314.2457)


   

(6Z,9Z,12Z,15Z)-tricosa-1,6,9,12,15-pentaene

(6Z,9Z,12Z,15Z)-tricosa-1,6,9,12,15-pentaene

C23H38 (314.2973)


An alkapentaene that is tricos-1-ene with 4 cis double bonds at positions 6,9,12 and 15.

   

(8E,10S)-10-hydroperoxy-8-octadecenoic acid

(8E,10S)-10-hydroperoxy-8-octadecenoic acid

C18H34O4 (314.2457)


A hydroperoxy fatty acid that is the (10S)-hydroperoxy derivative of (8E)-octadecenoic acid.

   

2-Hydroxyoctadecenoic acid

2-Hydroxyoctadecenoic acid

C18H34O4 (314.2457)


   

Hydroxynonadecanoic acid

Hydroxynonadecanoic acid

C19H38O3 (314.2821)


   
   
   

NA-Tryptamine 10:0

NA-Tryptamine 10:0

C20H30N2O (314.2358)


   

FAHFA 10:0/3O-8:0

FAHFA 10:0/3O-8:0

C18H34O4 (314.2457)


   

FAHFA 10:0/O-8:0

FAHFA 10:0/O-8:0

C18H34O4 (314.2457)


   

FAHFA 12:0/3O-6:0

FAHFA 12:0/3O-6:0

C18H34O4 (314.2457)


   

FAHFA 18:0;O

FAHFA 18:0;O

C18H34O4 (314.2457)


   

FAHFA 4:0/2O-14:0

FAHFA 4:0/2O-14:0

C18H34O4 (314.2457)


   

FAHFA 5:0/3O-13:0

FAHFA 5:0/3O-13:0

C18H34O4 (314.2457)


   

FAHFA 6:0/3O-12:0

FAHFA 6:0/3O-12:0

C18H34O4 (314.2457)


   

FAHFA 7:0/3O-11:0

FAHFA 7:0/3O-11:0

C18H34O4 (314.2457)


   

FAHFA 8:0/3O-10:0

FAHFA 8:0/3O-10:0

C18H34O4 (314.2457)


   

FAHFA 8:0/O-10:0

FAHFA 8:0/O-10:0

C18H34O4 (314.2457)


   

FAHFA 9:0/3O-9:0

FAHFA 9:0/3O-9:0

C18H34O4 (314.2457)


   

FAHFA 9:0/O-9:0

FAHFA 9:0/O-9:0

C18H34O4 (314.2457)


   
   

Hydroxy-9S,10R-epoxy-stearic acid

Hydroxy-9S,10R-epoxy-stearic acid

C18H34O4 (314.2457)


   
   
   

ST 22:2;O

ST 22:2;O

C22H34O (314.261)


   

3-methoxyoctadecanoic acid

3-methoxyoctadecanoic acid

C19H38O3 (314.2821)


   

methyl 2-[(3r,4s,6r)-4-ethyl-6-[(2s)-2-ethylhexyl]-6-methyl-1,2-dioxan-3-yl]acetate

methyl 2-[(3r,4s,6r)-4-ethyl-6-[(2s)-2-ethylhexyl]-6-methyl-1,2-dioxan-3-yl]acetate

C18H34O4 (314.2457)


   

2,3-dihydroxyoctadec-2-enoic acid

2,3-dihydroxyoctadec-2-enoic acid

C18H34O4 (314.2457)


   

(2s,4s,6e)-nonadec-6-ene-1,2,4-triol

(2s,4s,6e)-nonadec-6-ene-1,2,4-triol

C19H38O3 (314.2821)


   

(5R,8R,9R,10R,13R,14R)-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15-decahydrocyclopenta[a]phenanthren-3-one

NA

C22H34O (314.261)


{"Ingredient_id": "HBIN011914","Ingredient_name": "(5R,8R,9R,10R,13R,14R)-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15-decahydrocyclopenta[a]phenanthren-3-one","Alias": "NA","Ingredient_formula": "C22H34O","Ingredient_Smile": "NA","Ingredient_weight": "314.5","OB_score": "15.18728","CAS_id": "102848-61-3","SymMap_id": "SMIT03494","TCMID_id": "NA","TCMSP_id": "MOL001012","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5,5,6,7,9,13-hexamethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-one

5,5,6,7,9,13-hexamethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-one

C22H34O (314.261)


   

3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

C22H34O (314.261)


   

(2r)-2-methoxyoctadecanoic acid

(2r)-2-methoxyoctadecanoic acid

C19H38O3 (314.2821)


   

9a,11a-dimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

9a,11a-dimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C22H34O (314.261)


   

(4s,6s)-4-hydroxy-6-[(10r)-10-hydroxy-5,7-dimethylundecyl]oxan-2-one

(4s,6s)-4-hydroxy-6-[(10r)-10-hydroxy-5,7-dimethylundecyl]oxan-2-one

C18H34O4 (314.2457)


   

methyl 10-hydroxyoctadecanoate

methyl 10-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

(1r,3as,3bs,7s,9ar,9bs,11as)-9a,11a-dimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1r,3as,3bs,7s,9ar,9bs,11as)-9a,11a-dimethyl-1-(prop-1-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C22H34O (314.261)


   

(3ar,3br,5ar,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

(3ar,3br,5ar,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

C22H34O (314.261)


   

(1r,4s,6r,7s,9s,10r,13s)-5,5,6,7,9,13-hexamethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-one

(1r,4s,6r,7s,9s,10r,13s)-5,5,6,7,9,13-hexamethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-12-one

C22H34O (314.261)


   

4-hydroxy-6-(10-hydroxy-5,7-dimethylundecyl)oxan-2-one

4-hydroxy-6-(10-hydroxy-5,7-dimethylundecyl)oxan-2-one

C18H34O4 (314.2457)


   

docos-15-en-1,3-diyn-5-one

docos-15-en-1,3-diyn-5-one

C22H34O (314.261)


   

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-7-en-16-amine

6,13-dimethyl-7-azapentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icos-7-en-16-amine

C21H34N2 (314.2722)


   

(z)-methoxy[14-(pyridin-3-yl)tetradec-11-yn-1-ylidene]amine

(z)-methoxy[14-(pyridin-3-yl)tetradec-11-yn-1-ylidene]amine

C20H30N2O (314.2358)


   

methyl 2-[(3r,4r,6s)-4-ethyl-6-[(2s)-2-ethylhexyl]-6-methyl-1,2-dioxan-3-yl]acetate

methyl 2-[(3r,4r,6s)-4-ethyl-6-[(2s)-2-ethylhexyl]-6-methyl-1,2-dioxan-3-yl]acetate

C18H34O4 (314.2457)


   

(9r,10s,12e)-9,10-dihydroxyoctadec-12-enoic acid

(9r,10s,12e)-9,10-dihydroxyoctadec-12-enoic acid

C18H34O4 (314.2457)


   

nonadec-6-ene-1,2,4-triol

nonadec-6-ene-1,2,4-triol

C19H38O3 (314.2821)


   

methyl (10s)-10-hydroxyoctadecanoate

methyl (10s)-10-hydroxyoctadecanoate

C19H38O3 (314.2821)


   

(3ar,3br,5as,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

(3ar,3br,5as,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

C22H34O (314.261)


   

methyl 4-[(4-ethyl-2-methyl-5-propyloxolan-2-yl)methyl]-3-hydroxyhexanoate

methyl 4-[(4-ethyl-2-methyl-5-propyloxolan-2-yl)methyl]-3-hydroxyhexanoate

C18H34O4 (314.2457)


   

(9r,10s,12z)-9,10-dihydroxyoctadec-12-enoic acid

(9r,10s,12z)-9,10-dihydroxyoctadec-12-enoic acid

C18H34O4 (314.2457)


   

(5ar,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

(5ar,9ar,9br,11ar)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-one

C22H34O (314.261)


   

methyl 2-[4-ethyl-6-(2-ethylhexyl)-6-methyl-1,2-dioxan-3-yl]acetate

methyl 2-[4-ethyl-6-(2-ethylhexyl)-6-methyl-1,2-dioxan-3-yl]acetate

C18H34O4 (314.2457)


   

16-phenylhexadec-3-en-2-one

16-phenylhexadec-3-en-2-one

C22H34O (314.261)


   

(15z)-docos-15-en-1,3-diyn-5-one

(15z)-docos-15-en-1,3-diyn-5-one

C22H34O (314.261)


   

(3e)-16-phenylhexadec-3-en-2-one

(3e)-16-phenylhexadec-3-en-2-one

C22H34O (314.261)


   

methyl (3r,4r)-4-{[(2r,4r,5s)-4-ethyl-2-methyl-5-propyloxolan-2-yl]methyl}-3-hydroxyhexanoate

methyl (3r,4r)-4-{[(2r,4r,5s)-4-ethyl-2-methyl-5-propyloxolan-2-yl]methyl}-3-hydroxyhexanoate

C18H34O4 (314.2457)


   

5-[(2s,5r)-5-[(1r)-1-hydroxynonyl]oxolan-2-yl]pentanoic acid

5-[(2s,5r)-5-[(1r)-1-hydroxynonyl]oxolan-2-yl]pentanoic acid

C18H34O4 (314.2457)